Thousand Oaks law seminars focus on big questions in biotech
Organizers promise a steady progression from relatively anodyne topics like 3-D printers and intellectual property to touchier subjects, such as genetically engineered salmon, how animals are treated in biotech research and what ethical and legal obligations biotech researchers have when they appropriate and commercialize molecules traditionally used by indigenous cultures.
Read More →Ceres files for $20M offering
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.
Read More →Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Read More →Round 2: Atara raises $13.5M as T.O. biotech boom takes hold
Thousand Oaks-based Atara Biotherapeutics has brought on more investors to its second financing round, bringing the total raised to $52 million.
Read More →
Sponsored content:
2015-2016 Giving Guide
